Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
DiaMedica
Biotech
DiaMedica prepares to end 10-month stroke hold by halving dose
DiaMedica Therapeutics thinks it has the data to get out from under a stubborn FDA clinical hold for its stroke medication.
Nick Paul Taylor
May 16, 2023 9:20am
No remedy for DiaMedica as FDA maintains hold on stroke trial
Oct 27, 2022 9:30am
DiaMedica pulls off IPO to fund midphase stroke trial
Dec 7, 2018 9:35am
